Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 66,549 | 64,788 | 64,290 | 60,474 | 55,616 |
| Receivables | 13,068 | 9,741 | 8,506 | 9,656 | 7,052 |
| Inventories | 24,016 | 20,424 | 18,791 | 14,406 | 11,185 |
| Other current assets | 0 | 541 | 0 | 0 | 0 |
| TOTAL | $105,121 | $96,806 | $93,616 | $86,679 | $76,218 |
| Non-Current Assets | |||||
| PPE Net | 1,298 | 1,323 | 1,499 | 1,632 | 1,655 |
| Intangibles | 5,485 | 5,660 | 246 | 284 | 322 |
| Other Non-Current Assets | 2,425 | 2,617 | 2,778 | 2,930 | 3,142 |
| TOTAL | $9,208 | $9,600 | $4,523 | $4,846 | $5,119 |
| Total Assets | $114,329 | $106,406 | $98,139 | $91,525 | $81,337 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,277 | 10,796 | 12,742 | 13,680 | 10,632 |
| Accrued Expenses | 7,621 | 7,722 | 8,700 | 7,381 | 9,050 |
| Other current liabilities | 380 | 399 | 292 | 303 | 207 |
| TOTAL | $22,824 | $19,919 | $22,712 | $22,327 | $20,837 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 514 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,544 | 1,815 | 2,077 | 2,329 | 2,576 |
| TOTAL | $9,175 | $9,954 | $4,751 | $5,003 | $5,155 |
| Total Liabilities | $31,999 | $29,873 | $27,463 | $27,330 | $25,992 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 79,644 | 80,080 | 79,806 | 79,753 | 78,770 |
| Common Shares | 79 | 79 | 79 | 79 | 78 |
| Retained earnings | -158,210 | -164,528 | -168,660 | -173,238 | -176,847 |
| Other shareholders' equity | -3 | -9 | -9 | -4 | -5 |
| TOTAL | $82,330 | $76,533 | $70,676 | $64,195 | $55,345 |
| Total Liabilities And Equity | $114,329 | $106,406 | $98,139 | $91,525 | $81,337 |